Switch theme
Sign up to access all valuation multiples
Huaxia Eye Hospital Group Co Ltd is a ophthalmic medical chain group in China. It offers ophthalmology specialist medical services.
2004
n/a
LTM Revenue $585M
LTM EBITDA $107M
$1.8B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Huaxia Eye Hospital Group has a last 12-month revenue of $585M and a last 12-month EBITDA of $107M.
In the most recent fiscal year, Huaxia Eye Hospital Group achieved revenue of $553M and an EBITDA of $161M.
Huaxia Eye Hospital Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Huaxia Eye Hospital Group valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $553M | $567M | XXX | XXX | XXX |
| Gross Profit | $194M | $214M | XXX | XXX | XXX |
| Gross Margin | 35% | 38% | XXX | XXX | XXX |
| EBITDA | $161M | $107M | XXX | XXX | XXX |
| EBITDA Margin | 29% | 19% | XXX | XXX | XXX |
| Net Profit | $62.7M | $70.5M | XXX | XXX | XXX |
| Net Margin | 11% | 12% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Huaxia Eye Hospital Group's stock price is CNY 19 (or $3).
Huaxia Eye Hospital Group has current market cap of CNY 16.0B (or $2.2B), and EV of CNY 13.2B (or $1.8B).
See Huaxia Eye Hospital Group trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.8B | $2.2B | XXX | XXX | XXX | XXX | $0.10 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Huaxia Eye Hospital Group has market cap of $2.2B and EV of $1.8B.
Huaxia Eye Hospital Group's trades at 3.1x LTM EV/Revenue multiple, and 17.1x LTM EBITDA.
Analysts estimate Huaxia Eye Hospital Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Huaxia Eye Hospital Group and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $1.8B | XXX | XXX | XXX |
| EV/Revenue | 3.2x | XXX | XXX | XXX |
| EV/EBITDA | 17.1x | XXX | XXX | XXX |
| P/E | 31.3x | XXX | XXX | XXX |
| P/E/Growth | 1.2x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpHuaxia Eye Hospital Group's NTM/LTM revenue growth is 14%
Huaxia Eye Hospital Group's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, Huaxia Eye Hospital Group's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Huaxia Eye Hospital Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Huaxia Eye Hospital Group and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 3% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 19% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -34% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 33% | XXX | XXX | XXX | XXX |
| Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
| Opex per Employee | n/a | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 8% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 26% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Compass Pathways | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Huaxia Eye Hospital Group acquired XXX companies to date.
Last acquisition by Huaxia Eye Hospital Group was XXXXXXXX, XXXXX XXXXX XXXXXX . Huaxia Eye Hospital Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Huaxia Eye Hospital Group founded? | Huaxia Eye Hospital Group was founded in 2004. |
| Where is Huaxia Eye Hospital Group headquartered? | Huaxia Eye Hospital Group is headquartered in China. |
| Is Huaxia Eye Hospital Group publicy listed? | Yes, Huaxia Eye Hospital Group is a public company listed on SHE. |
| What is the stock symbol of Huaxia Eye Hospital Group? | Huaxia Eye Hospital Group trades under 301267 ticker. |
| When did Huaxia Eye Hospital Group go public? | Huaxia Eye Hospital Group went public in 2022. |
| Who are competitors of Huaxia Eye Hospital Group? | Similar companies to Huaxia Eye Hospital Group include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Huaxia Eye Hospital Group? | Huaxia Eye Hospital Group's current market cap is $2.2B |
| What is the current revenue of Huaxia Eye Hospital Group? | Huaxia Eye Hospital Group's last 12-month revenue is $585M. |
| What is the current EBITDA of Huaxia Eye Hospital Group? | Huaxia Eye Hospital Group's last 12-month EBITDA is $107M. |
| What is the current EV/Revenue multiple of Huaxia Eye Hospital Group? | Current revenue multiple of Huaxia Eye Hospital Group is 3.1x. |
| What is the current EV/EBITDA multiple of Huaxia Eye Hospital Group? | Current EBITDA multiple of Huaxia Eye Hospital Group is 17.1x. |
| What is the current revenue growth of Huaxia Eye Hospital Group? | Huaxia Eye Hospital Group revenue growth between 2023 and 2024 was 3%. |
| Is Huaxia Eye Hospital Group profitable? | Yes, Huaxia Eye Hospital Group is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
